Concept

A changed biomarker is not automatically a changed life

The dashboard can move before the destination is established.

About 1 min read

Before you use it

Use when
  • A product's benefit is inferred from a laboratory measure rather than how people feel, function or survive.

Keep this limit in mind

  • Some surrogate endpoints are well validated and useful. Do not reject all biomarkers or change care because a direct long-term endpoint was not measured.

An idea to explore.

Try this idea.

Inspect the example, try the idea in your situation, then check your next move.

Keep reading

The idea

A surrogate stands in for an outcome of interest. Ask what evidence validates that substitution in this context; an attractive mechanism alone does not finish the argument.

An example

A fictional intervention changes a measured molecule. Without suitable validation or outcome evidence, that is not yet proof that users feel better or live longer.

Check your result

Can you distinguish what was measured from the benefit being promised?

Save and practise this idea

My learning

Read. Recall. Repeat.

Save this idea and return to it on any device.

Use email
Keep exploring

Connected ideas

You are readingA changed biomarker is not automatically a changed life

Evidence and sources
Supports

A surrogate endpoint substitutes for a clinical outcome and requires context-specific evidence of its predictive value.

Claim basis: technical_definition. Claim limit: Some surrogates are well validated; others remain candidates. Source access: selected_html_passages; accessed on: 2026-09-17; inspected sections: ["What are clinical trial endpoints?", "How can biomarkers be used as surrogate endpoints?"]. Agent scope review: FDA defines a surrogate as a substitute for a direct measure of how a patient feels, functions or survives and explains that its validation depends on context. The card gives a fictional example and explicitly rules out changing care on this basis.

Surrogate Endpoint Resources for Drug and Biologic Development · Clinical trial endpoints; biomarkers as surrogate endpoints

All sources (1)
Edition and review

Version 0.1.0 · Published

Edition checked · 2026-11-12

Read this idea as JSON · Release details